STOCK TITAN

Emergent BioSolutions to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Emergent BioSolutions (NYSE:EBS) announced its upcoming participation in two major investor conferences. The company will present at the Wells Fargo 20th Annual Healthcare Conference on September 4, 2025, at 3:00 PM ET, and at the HCW 27th Annual Global Investment Conference on September 9, 2025, at 1:30 PM ET.

Senior management will be available for one-on-one meetings at both events. Investors can access the presentations and replays through the Investors section of Emergent's website.

Emergent BioSolutions (NYSE:EBS) ha annunciato la partecipazione a due importanti conferenze per investitori. La società presenterà al Wells Fargo 20th Annual Healthcare Conference il 4 settembre 2025 alle 15:00 ET e al HCW 27th Annual Global Investment Conference il 9 settembre 2025 alle 13:30 ET.

I vertici aziendali saranno disponibili per incontri one-to-one in entrambe le sedi. Gli investitori potranno consultare le presentazioni e le registrazioni nella sezione Investors del sito web di Emergent.

Emergent BioSolutions (NYSE:EBS) anunció su participación en dos importantes conferencias para inversores. La compañía presentará en el Wells Fargo 20th Annual Healthcare Conference el 4 de septiembre de 2025 a las 15:00 ET y en el HCW 27th Annual Global Investment Conference el 9 de septiembre de 2025 a la 13:30 ET.

La alta dirección estará disponible para reuniones individuales en ambos eventos. Los inversores podrán acceder a las presentaciones y a las reproducciones desde la sección Investors del sitio web de Emergent.

Emergent BioSolutions (NYSE:EBS)는 두 곳의 주요 투자자 컨퍼런스에 참가할 예정이라고 발표했습니다. 회사는 Wells Fargo 20th Annual Healthcare Conference에서 2025년 9월 4일 오후 3시(ET)에, HCW 27th Annual Global Investment Conference에서는 2025년 9월 9일 오후 1시 30분(ET)에 발표를 진행합니다.

경영진은 두 행사에서 일대일 미팅에 응할 예정입니다. 투자자들은 Emergent 웹사이트의 Investors 섹션을 통해 발표자료와 재방송을 확인할 수 있습니다.

Emergent BioSolutions (NYSE:EBS) a annoncé sa participation à deux grandes conférences pour investisseurs. La société présentera lors du Wells Fargo 20th Annual Healthcare Conference le 4 septembre 2025 à 15h00 ET, et au HCW 27th Annual Global Investment Conference le 9 septembre 2025 à 13h30 ET.

La direction générale sera disponible pour des rencontres individuelles lors des deux événements. Les investisseurs pourront consulter les présentations et les replays via la rubrique Investors du site web d'Emergent.

Emergent BioSolutions (NYSE:EBS) gab seine Teilnahme an zwei bedeutenden Investorenkonferenzen bekannt. Das Unternehmen wird am Wells Fargo 20th Annual Healthcare Conference am 4. September 2025 um 15:00 Uhr ET und am HCW 27th Annual Global Investment Conference am 9. September 2025 um 13:30 Uhr ET präsentieren.

Das Senior Management steht für Einzelgespräche auf beiden Veranstaltungen zur Verfügung. Investoren können die Präsentationen und Wiedergaben im Bereich Investors auf der Emergent-Website abrufen.

Positive
  • None.
Negative
  • None.

GAITHERSBURG, Md., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s senior management team will participate in the following investor conferences:

  • Wells Fargo 20th Annual Healthcare Conference
    September 4, 2025
    3:00 pm ET
    Webcast link here
    One-on-one meetings
  • HCW 27th Annual Global Investment Conference
    September 9, 2025
    1:30 PM ET
    Webcast link here
    One-on-one meetings

Please contact your conference representative to request one-on-one meetings.

Participants can view the presentations and replays by visiting the Investors page of Emergent’s website.

About Emergent BioSolutions
At Emergent, our mission is to protect and save lives. For over 25 years, we’ve been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today’s health challenges and tomorrow’s threat, visit our website and follow us on LinkedInXInstagramApple Podcasts and Spotify.

Investor Contact:
Richard S. Lindahl
Executive Vice President, CFO
lindahlr@ebsi.com  

Media Contact:
Assal Hellmer
Vice President, Communications
mediarelations@ebsi.com


FAQ

When is Emergent BioSolutions (EBS) presenting at the Wells Fargo Healthcare Conference 2025?

Emergent BioSolutions will present at the Wells Fargo Healthcare Conference on September 4, 2025 at 3:00 PM ET.

When is EBS presenting at the HCW Global Investment Conference 2025?

EBS will present at the HCW Global Investment Conference on September 9, 2025 at 1:30 PM ET.

How can investors access Emergent BioSolutions' conference presentations?

Investors can access the presentations and replays through the Investors page of Emergent's website.

Will Emergent BioSolutions offer one-on-one meetings at these conferences?

Yes, one-on-one meetings are available at both conferences. Interested parties should contact their conference representatives to schedule meetings.
Emergent Biosolutions Inc

NYSE:EBS

EBS Rankings

EBS Latest News

EBS Latest SEC Filings

EBS Stock Data

492.43M
51.72M
2.84%
70.04%
18.65%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
GAITHERSBURG